Search research articles
Contact Us
Filters
Showing results (231-240 of 247) with videos related to
Page
of 25
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 5, 2014
Occult primary, version 3.2014
David S Ettinger, Charles R Handorf, Mark Agulnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, et al.
Annals of Surgery
|
June 13, 2019
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial
John F Thompson, Lauren E Haydu, Roger F Uren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey
Glenn Geidel, Nathan Fekade, Katharina Raabe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
Cancer
|
November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
Danielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.
Transplantation and Cellular Therapy
|
December 20, 2025
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients
Lilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, et al.
Cancer Discovery
|
July 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy
Zachary Z Reinstein, Yue Zhang, Oscar E Ospina, et al.
Journal of the American College of Surgeons
|
December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
Kristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2022
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study
Carl-Jacob Holmberg, Lars Ny, Tina J Hieken, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 247) with videos related to
Sort By:
Page
of 25
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 5, 2014
Occult primary, version 3.2014
David S Ettinger, Charles R Handorf, Mark Agulnik, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2015
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, et al.
Annals of Surgery
|
June 13, 2019
Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial
John F Thompson, Lauren E Haydu, Roger F Uren, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey
Glenn Geidel, Nathan Fekade, Katharina Raabe, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
Cancer
|
November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
Danielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.
Transplantation and Cellular Therapy
|
December 20, 2025
Safety and efficacy of tumor-infiltrating lymphocyte (TIL) therapy with reduced-dose lymphodepleting conditioning in high-risk metastatic melanoma patients
Lilit Karapetyan, Joel Kuriakose, Elizabeth DiMaggio, et al.
Cancer Discovery
|
July 26, 2024
Preexisting Skin-Resident CD8 and γδ T-cell Circuits Mediate Immune Response in Merkel Cell Carcinoma and Predict Immunotherapy Efficacy
Zachary Z Reinstein, Yue Zhang, Oscar E Ospina, et al.
Journal of the American College of Surgeons
|
December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
Kristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2022
The efficacy of immune checkpoint blockade for melanoma in-transit with or without nodal metastases - A multicenter cohort study
Carl-Jacob Holmberg, Lars Ny, Tina J Hieken, et al.
Page
of 25